Byonyks X1: a New, Small, Portable APD Machine
Developed in Pakistan with U.S. R&D, an FDA application for the X1 was filed in Nov., 2023. Byonyks expects the X1 to be in patients’ homes in 2025. Later, the X2 and X3 will provide PD using ultrapure dialysate made on demand, which will reduce supply storage and delivery costs, as well as medical waste. Watch the 9-minute pitch video.
Read the full article » | Posted 06-14-2024
Related Articles
- Proof of Concept for Silicon Nanopore Membrane Implantable HD Posted 10-05-2026
- AWAK PD To Go Posted 10-05-2026
- The Lancet Digital Health published results of Humacyte’s Phase III clinical trial of its V007 acellular tissue engineered vessel (ATEV) HD access Posted 09-18-2026
- Humacyte, Inc. announced Robert J. Kossman, MD, FACP, FASN and Prabir Roy-Chaudhury, MD, PhD, FASN have joined the company as advisors. Posted 08-21-2026

